The DOI matches its Crossref record; 271 of the 272 references it cites were found in a registry or an index.
Short-chain fatty acids, secondary bile acids and indoles: gut microbial metabolites with effects on enteroendocrine cell function and their potential as therapies for metabolic disease
Open accessAbstract
The gastrointestinal tract hosts the largest ecosystem of microorganisms in the body. The metabolism of ingested nutrients by gut bacteria produces novel chemical mediators that can influence chemosensory cells lining the gastrointestinal tract. Specifically, hormone-releasing enteroendocrine cells which express a host of receptors activated by these bacterial metabolites. This review will focus on the activation mechanisms of glucagon-like peptide-1 releasing enteroendocrine cells by the three main bacterial metabolites produced in the gut: short-chain fatty acids, secondary bile acids and indoles. Given the importance of enteroendocrine cells in regulating glucose homeostasis and food intake, we will also discuss therapies based on these bacterial metabolites used in the treatment of metabolic diseases such as diabetes and obesity. Elucidating the mechanisms gut bacteria can influence cellular function in the host will advance our understanding of this fundamental symbiotic relationship and unlock the potential of harnessing these pathways to improve human health.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“the gut microbiota-derived metabolites, including SCFAs, secondary BAs, and indoles, have been demonstrated to modulate gut hormone secretion from EECs.”
From Microbiota–gut–brain axis and its therapeutic applications in neurodegenerative diseases (2024) · cites this paper as [547]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–271 of 271
Tryptophan Predicts the Risk for Future Type 2 Diabetes
Chen, T., Zheng, X., Ma, X., Bao, Y., Ni, Y., Hu, C., Rajani, C., Huang, F., Zhao, A., Jia, W., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0162192 · Cited by 115
Miyazaki, T., Ise, M., Hirata, M., Endo, K., Ito, Y., Seo, H., & Niwa, T. (1997) · PubMed · Cited by 112
Hudson, B. D., Due‐Hansen, M. E., Christiansen, E., Hansen, A. M., Mackenzie, A. E., Murdoch, H., Pandey, S. K., Ward, R. J., Márquez, R., Tikhonova, I. G., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.455337 · Cited by 111 · cited 3×
“A possible convergence of downstream signaling pathways involving the phosphorylation of extracellular signal-regulated kinases (ERK) is possible as both Gaqand Gai-coupled signaling pathways can activate this effector molecule (94).”
BackgroundShang, Q., Saumoy, M., Holst, J. J., Salen, G., & Xu, G. (2009) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00362.2009 · Cited by 110
Indole Transport across Escherichia coli Membranes
Piñero-Fernández, S., Chimerel, C., Keyser, U. F., & Summers, D. (2011) · Journal of Bacteriology · doi:10.1128/jb.01477-10 · Cited by 110
β-Arrestin 2 Mediates G Protein-Coupled Receptor 43 Signals to Nuclear Factor-κB
Lee, S. U., In, H. J., Kwon, M. S., Park, B.-O., Jo, M., Kim, M.-O., Cho, S., Lee, S., Lee, H., Kwak, Y. S., et al. (2013) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b13-00312 · Cited by 109
FFAR2‐FFAR3 receptor heteromerization modulates short‐chain fatty acid sensing
Ang, Z., Xiong, D., Wu, M., & Ding, J. L. (2017) · The FASEB Journal · doi:10.1096/fj.201700252rr · Cited by 109 · cited 1×
“In monocytes, FFA3 activation increased intracellular calcium signaling and recruited b-arrestin 2 (104), though, the involvement of b-arrestin in an EEC system has yet to be determined.”
BackgroundDao, M. C., Belda, E., Prifti, E., Everard, A., Kayser, B. D., Bouillot, J., Chevallier, J., Pons, N., Chatelier, E. L., Ehrlich, S. D., et al. (2019) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00140.2019 · Cited by 103
Role of multiple efflux pumps in Escherichia coli in indole expulsion
Kawamura‐Sato, K., Shibayama, K., Horii, T., Iimuma, Y., Arakawa, Y., & Ohta, M. (1999) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.1999.tb08748.x · Cited by 101
Herrema, H., Meissner, M., van Dijk, T. H., Brufau, G., Boverhof, R., Oosterveer, M. H., Reijngoud, D., Müller, M. M., Stellaard, F., Groen, A. K., et al. (2009) · Hepatology · doi:10.1002/hep.23408 · Cited by 96
Remission of type 2 diabetes after Roux-en-Y gastric bypass is associated with greater weight loss
Kadera, B. E., Lum, K., Grant, J. P., Pryor, A. D., Portenier, D. D., & DeMaria, E. J. (2009) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2009.02.007 · Cited by 95
Pais, R., Gribble, F. M., & Reimann, F. M. (2015) · Peptides · doi:10.1016/j.peptides.2015.07.019 · Cited by 94
Inflammation stimulates niacin receptor (GPR109A/HCA2) expression in adipose tissue and macrophages
Feingold, K. R., Moser, A. H., Shigenaga, J. K., & Grünfeld, C. (2014) · Journal of Lipid Research · doi:10.1194/jlr.m050955 · Cited by 90
Anastasovska, J., Arora, T., Sanchez-Canon, G. J., Parkinson, J. R. C., Tuohy, K. M., Gibson, G. R., Nadkarni, N. A., So, P., Goldstone, A. P., Thomas, E. L., et al. (2012) · Obesity · doi:10.1038/oby.2012.6 · Cited by 90
Gutiérrez‐Díaz, I., Fernández-Navarro, T., Salazar, N., Bartolomé, B., Moreno-Arribas, M. V., deAndrés‐Galiana, E. J., Fernández‐Martínez, J. L., Reyes‐Gavilán, C. G. D. L., Gueimonde, M., & González, S. (2016) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.6b04408 · Cited by 90
da Silva, L. G., Ferguson, B. S., de Ávila, A. S., & Faciola, A. P. (2018) · Journal of Animal Science · doi:10.1093/jas/sky373 · Cited by 90 · cited 1×
“In the colon, HDACs are inhibited by both butyrate and propionate (85, 86), though butyrate is the most effective inhibitor of HDACs (110, 111).”
BackgroundGlasssmith, L. L., Calero‐Nieto, F. J., Jawaid, W., Larraufie, P., Kay, R. G., Göttgens, B., Reimann, F. M., & Gribble, F. M. (2017) · Molecular Metabolism · doi:10.1016/j.molmet.2017.07.014 · Cited by 89
Elevated blood acetate as indicator of fast ethanol elimination in chronic alcoholics
Nuutinen, H. U., Lindros, K. O., Hekali, P. E., & Salaspuro, M. P. (1985) · Alcohol · doi:10.1016/0741-8329(85)90090-4 · Cited by 88 · cited 1×
“Notably, the liver can generate significant levels of acetate (~1 mM) during bouts of chronic alcohol consumption that can enter circulation and impact gastrointestinal function (51).”
BackgroundIndole-3-Propionic Acid, a Tryptophan-Derived Bacterial Metabolite, Reduces Weight Gain in Rats
Konopelski, P., Konop, M., Gawryś-Kopczyńska, M., Podsadni, P., Szczepańska, A., & Ufnal, M. (2019) · Nutrients · doi:10.3390/nu11030591 · Cited by 87
Expression of odorant receptor Olfr78 in enteroendocrine cells of the colon
Fleischer, J., Bumbalo, R., Bautze, V., Strotmann, J. M., & Breer, H. (2015) · Cell and Tissue Research · doi:10.1007/s00441-015-2165-0 · Cited by 86 · cited 2×
“Expression of Olfr78 is localized in murine EECs of the colon, especially PYY-positive cells (87) and serotonin-producing enterochromaffin cells (106), though the function of the receptor remains unclear.”
BackgroundHansen, M., Sonne, D. P., Mikkelsen, S. U., Gluud, L. L., Vilsbøll, T., & Knop, F. K. (2017) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2017.01.011 · Cited by 86
Forbes, S. C., Stafford, S., Coope, G., Heffron, H., Real, K., Newman, R., Davenport, R., Barnes, M., Grosse, J., & Cox, H. M. (2015) · Diabetes · doi:10.2337/db15-0481 · Cited by 85
Huang, K., Wang, M. M., Kulinich, A. O., Yao, H. L., Ma, H. Y., Reyes-Martínez, J. E., Duan, X. C., Chen, H., Cai, Z. P., Flitsch, S. L., et al. (2015) · Carbohydrate Research · doi:10.1016/j.carres.2015.08.001 · Cited by 84
Higher circulating bile acid concentrations in obese patients with type 2 diabetes
Vincent, R. P., Omar, S., Ghozlan, S., Taylor, D. R., Cross, G. F., Sherwood, R. A., Fändriks, L., Olbers, T., Werling, M., Alaghband‐Zadeh, J., et al. (2013) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1177/0004563212473450 · Cited by 84
Bile Acids Increase Independently From Hypocaloric Restriction After Bariatric Surgery
Jahansouz, C., Xu, H., Hertzel, A. V., Serrot, F. J., Kvalheim, N., Cole, A. J., Abraham, A. A., Luthra, G., Ewing, K., Leslie, D. B., et al. (2015) · Annals of Surgery · doi:10.1097/sla.0000000000001552 · Cited by 84
Butyrate modulates diabetes-linked gut dysbiosis: epigenetic and mechanistic modifications
Noureldein, M. H., Bitar, S., Youssef, N., Azar, S., & Eid, A. A. (2020) · Journal of Molecular Endocrinology · doi:10.1530/jme-19-0132 · Cited by 84
Lund, M. L., Sorrentino, G., Egerod, K. L., Kroone, C., Mortensen, B., Knop, F. K., Reimann, F. M., Gribble, F. M., Drucker, D. J., de Koning, E. J. P., et al. (2020) · Diabetes · doi:10.2337/db19-0764 · Cited by 84
Mráz, M., Lacinová, Z., Kaválková, P., Haluzíková, D., Trachta, P., Drápalová, J., Hanušová, V., & Haluzı́k, M. (2011) · Physiological Research · doi:10.33549/physiolres.932099 · Cited by 82
A Novel Allosteric Activator of Free Fatty Acid 2 Receptor Displays Unique Gi-functional Bias
Bolognini, D., Hodge, D., Nilsson, K. A., Petersson, A., Donnelly, I., Sergeev, E., König, G. M., Kostenis, E., Kurowska‐Stolarska, M., Miller, A. M., et al. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.736157 · Cited by 81
Microbial regulation of the L cell transcriptome
Arora, T., Akrami, R., Pais, R., Bergqvist, L., Johansson, B. R., Schwartz, T. W., Reimann, F. M., Gribble, F. M., & Bäckhed, F. (2018) · Scientific Reports · doi:10.1038/s41598-017-18079-2 · Cited by 76 · cited 1×
“As further support, there is a reduction of GLP-1 releasing L-cells in germ-free mice lacking intestinal microbiota (115, 116).”
BackgroundLin, H. V., Efanov, A. M., Fang, X., Beavers, L. S., Wang, X., Wang, J., Valcarcel, I. C. G., & Ma, T. (2016) · PLoS ONE · doi:10.1371/journal.pone.0157298 · Cited by 71
The Metabolism of Chenodeoxycholic Acid to β‐Muricholic Acid in Rat Liver
Botham, K. M., & Boyd, G. S. (1983) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1983.tb07550.x · Cited by 69 · cited 2×
“Hydroxylation and modification of cholesterol in the liver generates the primary bile acids, cholic acid (CA) and chenodeoxycholic acid (CDCA) in humans (57), and CA and muricholic acid (MCA) in rodents (58).”
BackgroundBile acids drive colonic secretion of glucagon-like-peptide 1 and peptide-YY in rodents
Christiansen, C. B., Trammell, S. A. J., Albrechtsen, N. J. W., Schoonjans, K., Albrechtsen, R., Gillum, M. P., Kuhre, R. E., & Holst, J. J. (2019) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00010.2019 · Cited by 69 · cited 2×
“Transport of bile acids across the epithelial layer is critical for gut hormone secretion from EECs as blocking ASBT in the terminal ileum reduced GLP-1 release (129, 132).”
BackgroundPriori, D., Colombo, M., Clavenzani, P., Jansman, A. J. M., Lallès, J.-P., Trevisi, P., & Bosi, P. (2015) · PLOS ONE · doi:10.1371/journal.pone.0129501 · Cited by 66 · cited 1×
“Expression of Olfr78 is localized in murine EECs of the colon, especially PYY-positive cells (87) and serotonin-producing enterochromaffin cells (106), though the function of the receptor remains unclear.”
BackgroundInubushi, T., Kamemura, N., Oda, M., Sakùrai, J., Nakaya, Y., Harada, N., Suenaga, M., Matsunaga, Y., Ishidoh, K., & Katunuma, N. (2012) · Journal of Nutritional Science and Vitaminology · doi:10.3177/jnsv.58.415 · Cited by 65
Goldspink, D. A., Lu, V. B., Billing, L., Larraufie, P., Tolhurst, G., Gribble, F. M., & Reimann, F. M. (2017) · Molecular Metabolism · doi:10.1016/j.molmet.2017.11.005 · Cited by 62 · cited 3×
“Multiple studies have identified bile acids as a robust trigger of GLP-1 release (28, 47, 129, 130) and bile acid-triggered GLP-1 release was diminished in a GPBAR1 knockout model (129, 133–135).”
BackgroundSelf-citationThe Natural Metabolite 4-Cresol Improves Glucose Homeostasis and Enhances β-Cell Function
Brial, F., Alzaïd, F., Sonomura, K., Meneyrol, K., Lay, A. L., Pean, N., Neves, A., Chilloux, J., Hedjazi, L., Sato, T.-A., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.01.066 · Cited by 59
Modvig, I. M., Kuhre, R. E., Jepsen, S. L., Xu, S. F. S., Engelstoft, M. S., Egerod, K. L., Schwartz, T. W., Ørskov, C., ROSENKILDE, M. M., & Holst, J. J. (2021) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00026.2021 · Cited by 58
Gq and Gs signaling acting in synergy to control GLP-1 secretion
Hauge, M., Ekberg, J. H., Engelstoft, M. S., Timshel, P. N., Madsen, A. N., & Schwartz, T. W. (2016) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2016.11.024 · Cited by 57 · cited 17×
“EECs express HDACs and SCFA-responsive GPCRs (85–89), except HCAR2 which is primarily localized in adipose and immune tissue (83).”
BackgroundInfluentialAntiobesity activities of indole-3-carbinol in high-fat-diet–induced obese mice
Chang, H., Wang, M., Chan, M.-H., Chiu, Y.-S., & Chen, Y. (2011) · Nutrition · doi:10.1016/j.nut.2010.09.006 · Cited by 54
Bile acid synthesis in primary cultures of rat and human hepatocytes
Ellis, E. C. S., Goodwin, B. J., Abrahamsson, A., Liddle, C., Mode, A., Rudling, M. J., Björkhem, I., & Einarsson, C. (1998) · Hepatology · doi:10.1002/hep.510270241 · Cited by 51 · cited 2×
“Hydroxylation and modification of cholesterol in the liver generates the primary bile acids, cholic acid (CA) and chenodeoxycholic acid (CDCA) in humans (57), and CA and muricholic acid (MCA) in rodents (58).”
BackgroundHDAC1 and HDAC2 collectively regulate intestinal stem cell homeostasis
Zimberlin, C., Lancini, C., Sno, R., Rosekrans, S. L., McLean, C. M., Vlaming, H., van den Brink, G. R., Bots, M. L., Medema, J. P., & Dannenberg, J. (2015) · The FASEB Journal · doi:10.1096/fj.14-257931 · Cited by 49 · cited 1×
“HDAC activity has been implicated in gut development (108) and immune tissue regulation (85, 109).”
BackgroundNishida, A., Miyamoto, J., Shimizu, H., & Kimura, I. (2021) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2021.03.167 · Cited by 49 · cited 1×
“Acetate and propionate, but not butyrate, are potent endogenous ligands for these receptors (87, 105).”
BackgroundLiraglutide 3.0 mg for weight management: weight-loss dependent and independent effects
Bays, H., Pi-Sunyer, X., Hemmingsson, J. U., Claudius, B., Jensen, C. B., & Van Gaal, L. (2017) · Current Medical Research and Opinion · doi:10.1080/03007995.2016.1251892 · Cited by 48
Papandreou, C., Li, J., Liang, L., Bulló, M., Zheng, Y., Ruiz‐Canela, M., Yu, E., Guasch‐Ferré, M., Razquín, C., Clish, C. B., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-39441-6 · Cited by 48
Hypoglycaemic and Hypolipidemic Activities of Rauwolfia serpentina in Alloxan-Induced Diabetic Rats
Qureshi, S. A., Nawaz, A., Udani, S. K., & Azmi, B. M. (2009) · International Journal of Pharmacology · doi:10.3923/ijp.2009.323.326 · Cited by 46
Marino, S. D., Carino, A., Masullo, D., Finamore, C., Marchianò, S., Cipriani, S., Leva, F. S. D., Catalanotti, B., Novellino, E., Limongelli, V., et al. (2017) · Scientific Reports · doi:10.1038/srep43290 · Cited by 45
Olfactory Receptor OR51E1 Mediates GLP-1 Secretion in Human and Rodent Enteroendocrine L Cells
Han, Y. E., Kang, C. W., Oh, J. H., Park, S. H., Ku, C. R., Cho, Y. H., Lee, M. K., & Lee, E. J. (2018) · Journal of the Endocrine Society · doi:10.1210/js.2018-00165 · Cited by 45 · cited 9×
“AhR aryl hydrocarbon receptor ASBT apical sodium-dependent bile acid transporter ATP adenosine triphosphate BSH bile salt hydrolase C2/C3/C4 acetate/propionate/butyrate CA cholic acid cAMP cyclic adenosine monophosphate CAR constitutive androstane receptor CaSR calcium-sensing receptor CDCA chenodeoxycholic acid CYP45…”
BackgroundInfluentialPregnane X Receptor (PXR) at the Crossroads of Human Metabolism and Disease
Koutsounas, I. S., Theocharis, S. E., Patsouris, E., & Giaginis, C. (2013) · Current Drug Metabolism · doi:10.2174/1389200211314030009 · Cited by 44
Schwartz, S. L., Lai, Y., Xu, J., Abby, S. L., Misir, S., Jones, M. R., & Nagendran, S. (2010) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2009.0049 · Cited by 44
Suzuki, K., Iwasaki, K., Murata, Y., Harada, N., Yamane, S., Hamasaki, A., Shibue, K., Joo, E., Sankoda, A., Fujiwara, Y., et al. (2017) · Journal of Diabetes Investigation · doi:10.1111/jdi.12681 · Cited by 42 · cited 1×
“Interestingly, the distal small intestine and colon harbor the greatest density of PYY and GLP-1 releasing L-cells (41), paralleling the distribution of gut bacteria (42).”
BackgroundCaengprasath, N., González‐Abuín, N., Shchepinova, M. M., Ma, Y., Inoue, A., Tate, E. W., Frost, G. S., & Hanyaloglu, A. C. (2020) · iScience · doi:10.1016/j.isci.2020.101449 · Cited by 40
Azmi, M. B., & Qureshi, S. A. (2012) · Advances in Pharmacological Sciences · doi:10.1155/2012/376429 · Cited by 38
Energy balance and type 2 diabetes: A report from the Shanghai Women's Health Study
Villegas, R., Shu, X., Yang, G., Matthews, C. E., Li, H., Cai, H., Gao, Y., & Zheng, W. (2008) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2008.06.003 · Cited by 38
Pastorino, S., Richards, M., Pierce, M. B., & Ambrosini, G. L. (2016) · British Journal Of Nutrition · doi:10.1017/s0007114516000672 · Cited by 36
The functional impact of G protein-coupled receptor 142 (Gpr142) on pancreatic β-cell in rodent
Al-Amily, I. M., Dunér, P., Groop, L., & Salehi, A. A. (2019) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-019-02262-7 · Cited by 36 · cited 2×
“The signaling mechanisms in EEC L-cells downstream of GPR142 activation is thought to be similar to pathways elucidated in other secretory cell types such as pancreatic b-cells (152).”
BackgroundMethodGPR142 Agonists Stimulate Glucose-Dependent Insulin Secretion via Gq-Dependent Signaling
Wang, J., Carrillo, J. J., & Lin, H. V. (2016) · PLoS ONE · doi:10.1371/journal.pone.0154452 · Cited by 35 · cited 1×
“Both Gaq and Gas-proteins are thought to be recruited to increase intracellular IP3 and cAMP levels, respectively (152, 153).”
Backgroundde la Escalera, L. M., Kyrou, I., Vrbíková, J., Hainer, V., Šrámková, P., Fried, M., Piya, M. K., Kumar, S., Tripathi, G., & McTernan, P. G. (2017) · BMC Medicine · doi:10.1186/s12916-017-0797-5 · Cited by 32
XiuYing, Z., Xian, Y., Wang, C., Ding, L., Meng, X., Zhu, W., & Hang, S. (2018) · Journal of Veterinary Science · doi:10.4142/jvs.2018.19.2.179 · Cited by 32 · cited 1×
“The signaling mechanisms of CaSR in EEC L-cells have not been fully characterized, but in other duodenal EEC populations activated CaSR couples to Gaq-protein and downstream effectors PKC and IP3 receptors (154).”
BackgroundGartner, S. N., Aidney, F. C., Klockars, A., Prosser, C. G., Carpenter, E. A., Isgrove, K., Levine, A. S., & Olszewski, P. K. (2018) · Appetite · doi:10.1016/j.appet.2018.02.015 · Cited by 27
Mercer, K. E., Yeruva, L., Pack, L., Graham, J. L., Stanhope, K. L., Chintapalli, S. V., Wankhade, U. D., Shankar, K., Havel, P. J., Adams, S. H., et al. (2020) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00105.2020 · Cited by 27
Diet Is a Stronger Covariate than Exercise in Determining Gut Microbial Richness and Diversity
Yun, E.-J., Imdad, S., Jang, J.-H., Park, J.-H., So, B., Kim, J., & Kang, C. (2022) · Nutrients · doi:10.3390/nu14122507 · Cited by 22
Liu, W., Chen, P.-H., & Chen, L.-W. (2020) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2020.108384 · Cited by 21
Osuga, Y., Harada, K., & Tsuboi, T. (2021) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2021.12.043 · Cited by 21
Shukla, A., & Srinivasan, B. P. (2012) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2012.07.012 · Cited by 18
Therapeutic Opportunities of GPBAR1 in Cholestatic Diseases
Zhang, F., Xiao, X., Li, Y., Wu, H., Deng, X., Jiang, Y., Zhang, W., Wang, J., Ma, X., & Zhao, Y. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.805269 · Cited by 18
Inhibition of hepatic gluconeogenesis by tryptophan metabolites in rats and guinea pigs
Smith, S. A. C., ELLIOTT, K. R. F., & Pogson, C. I. (1979) · Biochemical Pharmacology · doi:10.1016/0006-2952(79)90196-5 · Cited by 16
Wang, W., Wang, X., Liu, L., Liu, Z., Han, T., Sun, C., & Yang, X. (2022) · Obesity · doi:10.1002/oby.23343 · Cited by 12
Effects of active farnesoid X receptor on GLUTag enteroendocrine L cells
Niss, K., Jakobsson, M. E., Westergaard, D., Belling, K., Olsen, J. V., & Brunak, S. (2020) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2020.110923 · Cited by 8
Koffert, J., Lahti, L., Nylund, L., Salminen, S., Hannukainen, J. C., Salminen, P. T. P., de Vos, W. M., & Nuutila, P. (2020) · PeerJ · doi:10.7717/peerj.10442 · Cited by 8
Phuah, P., Cheng, S., Norton, M., Roberts, A. G., Otsubo, E., Gribble, F. M., Reimann, F. M., Hanyaloglu, A. C., Owen, B. M., & Murphy, K. (2021) · Endocrine Abstracts · doi:10.1530/endoabs.77.oc3.5 · Cited by 2 · cited 1×
“Acute application of indole increased GLP-1 secretion by increasing calcium mobilization in L-cells (44, 155) (Figure 4).”
Background
Flagged first, then by citations
1 of the 272 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Microbiota–gut–brain axis and its therapeutic applications in neurodegenerative diseases
Loh, J. S., Mak, W. Q., Tan, L. K. S., Ng, C. X., Chan, H. H., Yeow, S. H., Foo, J. B., Ong, Y. S., How, C. W., & Khaw, K. Y. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01743-1 · Cited by 1,193
Li, Z. H. (2024) · Gut · doi:10.1136/gutjnl-2024-331880 · Cited by 79
Gut dysbiosis in patients with chronic pain: a systematic review and meta-analysis
Goudman, L., Demuyser, T., Pilitsis, J. G., Billot, M., Manuel Roulaud, B., Rigoard, P., & Moens, M. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1342833 · Cited by 82
Jameson, K. G., Kazmi, S. A., Ohara, T. E., Son, C., Yu, K. B., Mazdeyasnan, D., Leshan, E., Vuong, H. E., Paramo, J., Lopez-Romero, A., et al. (2024) · iScience · doi:10.1016/j.isci.2024.111699 · Cited by 88
“57 Moreover, EECs are enriched for FFAR2 and TGR5 compared to other epithelial cell subtypes (Figures S7B–S7C).”
Microbiota in cancer: current understandings and future perspectives
Yao, Y., Zhu, Y., Chen, K., Chen, J., Li, Y., Li, D., & Wei, P. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02335-3 · Cited by 56
Metadata
- Authors
- Masse, K. E., & Lu, V. B.
- Affiliations
- Western University (CA)
- Corresponding author
- Lu, Van B.
- ORCID
- Lu, Van B.
- Venue
- Frontiers in Endocrinology
- Publisher
- Frontiers Media SA
- Published
- 2023-07-25
- Volume
- 14
- Pages
- 1169624-1169624
- ISSN
- 1664-2392 (ISSN-L)
- PMC
- PMC10407565
- OpenAlex
- W4385251361
- Cited by
- 120
- References
- 272
- Citations by year
- 2026: 66 · 2025: 23 · 2024: 29 · 2023: 2
- FWCI
- 3.16
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Frontiers in Endocrinology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Natural Sciences and Engineering Research Council of Canada
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- short-chain fatty acids, secondary bile acids, indole, gut microbiota metabolites, enteroendocrine cells, glucagon-like peptide-1, glucose homeostasis, food intake regulation, diabetes mellitus, obesity, metabolic disease treatment, gut microbiota, host-microbe symbiosis
- MeSH terms
- Gastrointestinal Microbiome, Bacteria, Bile Acids and Salts, Fatty Acids, Volatile, Humans, Indoles, Metabolic Diseases, Ecosystem, Enteroendocrine Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review